NTRB

NutribandB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

NTRB vs peer average

86/100

NTRB vs. peer average (B vs. D)

Grade spread

C 2 · D 3 · F 4

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

KALA is the first available peer comparator.

KALA BIO is only a same-sector, similar-market-cap reference; its ophthalmology focus means it should not be used to infer AVERSA Fentanyl regulatory odds or commercialization potential.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerKALAKALA BIO

NTRB

Nutriband

KALA

KALA BIO

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs KALA

NTRB / KALA

Grade Position

Above peers

NTRB vs. peer average (B vs. D)

86/100

Momentum

NTRB

Value

NTRB

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs NTRB

40/100

20/100

40/100

Greenland Mines Ltd Common

20/100

ATOS

Atossa Therapeutics Inc Common

20/100

KALA is the first peer returned for this comparison set.